Aminex Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of a novel small molecule combination therapy for the treatment of a broad range of cancer indications. Aminex has advanced AMXT 1501 + DFMO through target discovery, patenting, pre-clinical research and now into clinical development for the potential benefit of cancer patients.
Company Details
- Employees
- 6
- Founded
- -
- Phone
- (425) 286-4222
- ma****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aminextherapeutics.com
Aminex Therapeutics Questions
Aminex Therapeutics's helpline number is (425) 286-4222
Aminex Therapeutics's website is aminextherapeutics.com
Aminex Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aminex-therapeutics
Aminex Therapeutics has
6 employees.
View email and phone details for 6
employees at Aminex Therapeutics.
Aminex Therapeutics's industry is
Biotechnology Research
Aminex Therapeutics's top competitors are
Elios Therapeutics, Llc,
Anebulo Pharmaceuticals,
Angstrom Bio, Inc.,
Xbiotech Usa, Inc.,
Maxwell Biosciences,
Curtana Pharmaceuticals,
Alafair Biosciences, Inc.,
Genprex, Inc.,
Asuragen, A Bio-Techne Brand,
Celling Biosciences.
Aminex Therapeutics's support email address is markburns@aminextherapeutics.com
Aminex Therapeutics's categories are Biotechnology Research
Aminex Therapeutics's founding year is 2008
